Rc. Pereira et al., Bone morphogenetic proteins induce gremlin, a protein that limits their activity in osteoblasts, ENDOCRINOL, 141(12), 2000, pp. 4558-4563
Bone morphogenetic proteins (BMP) induce the differentiation of cells of th
e osteoblastic lineage and enhance the function of the osteoblast. Growth f
actor activity is regulated by binding proteins, and we previously showed t
hat BMPs induce noggin, a glycoprotein that binds and blocks BMP action. Re
cently, additional BMP antagonists, such as gremlin, have been described, b
ut there is no information about their expression or function in osteoblast
s. We tested for the expression of gremlin and studied its induction by BMP
s in cultures of osteoblast-enriched cells from 22-day-old fetal rat calvar
iae (Ob cells). BMP-2 caused a time- and dose-dependent increase in gremlin
messenger RNA and polypeptide levels, as determined by Northern and Wester
n blot analyses. The effects of BMP-2 on gremlin transcripts were independe
nt of new protein synthesis. BMP-2 increased the rate of gremlin transcript
ion as determined by nuclear run-on assays. Fibroblast growth factor-a and
platelet-derived growth factor BE also induced gremlin, but other hormones
and growth factors had no effect. Gremlin prevented the stimulatory effects
of BMP-2 on DNA, collagen, noncollagen protein synthesis, and alkaline pho
sphatase activity in Ob cells. In conclusion, BMPs induce gremlin transcrip
tion in Ob cells, a mechanism that probably limits BMP action in osteoblast
s.